Monday, 27 March 2017

AstraZeneca wins approval for lung cancer pill in China

LONDON (Reuters) - AstraZeneca said on Monday it had won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)